Abstract

Multidrug-resistant tuberculosis (MDR-TB), caused by the bacterium, Mycobacterium tuberculosis, is resistant to both isoniazid and rifampicin and is a phenomenon threatening to destabilize global tuberculosis control. Taiwan's Centers for Disease Control implemented a patient-centered DOTS (directly observed treatment, short-course)-Plus program for MDR-TB patients in May 2007. We report the case of a 71-year-old MDR-TB patient who successfully completed 18 months of MDR-TB treatment under the DOTS-Plus program, beginning October 2007. A third-generation (3G) mobile videophone was used to watch the patient take medicine throughout his course of treatment. His acceptance of the program and compliance with monitoring by videophone DOT (V-DOT) were excellent. We conclude that V-DOT can be an effective approach to case management for MDR-TB patients and can achieve a high level of adherence in selected cooperative cases in Taiwan.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.